EXECUTIVE ADVISORY BOARD

The CLP Executive Advisory Board (EAB) has been an integral to the growth and success of the Institute. Founded in 2005, the Board includes business leaders, entrepreneurs, researchers, physicians, and tech experts. The EAB provides members with a gateway to the world of transdisciplinary biomedical discovery, innovation, and education. Board members contribute their individual strengths to the Institute in the form of business advice and assistance in commercializing innovations, insight into educational programs, feedback on operations, strategic plans, marketing, fundraising, and individual philanthropy.

James Basta

James Basta

Vice President, Chief US Commercial Counsel, Biogen Idec

Michael Brown

CEO, Euronet Worldwide

Andrew Chan

Andrew Chan

Senior Vice President of Research Biology, Genentech

John Chen

COO, Hilco Global

Stuart Cornew

Stuart Cornew

Managing Director, AnswerMine

Steven Deitcher

Steven Deitcher

Co-founder, President, CEO and Board Member, Medeor Therapeutics

Barbara Dyson

Barbara Dyson

Principal, Dyson, Dyson and Dunn

Timothy Krauskopf

Timothy Krauskopf

Principal, Round Lake Designs

Patrick Martin

Patrick Martin

Principal, Martin Investment Management, LLC

Mani Mohindru

Mani Mohindru

CFO, Chief Strategy Officer, Cara Therapeutics

Laura Robertson

Laura Robertson

Director of Clinical Research, MyoKardia

Chandler Robinson

Chandler Robinson

CEO, Monopar Therapeutics

Tracy Schwartz Ward

Tracy Schwartz Ward

Principal, Schwartz Capital Group

Sujal Shah

Sujal Shah

President and CEO, CymaBay Therapeutics

Myung K. Shin

Myung K. Shin

Director, Genetics and Pharmacogenomics, Merck & Co., Inc.

Ulrich Thienel

Ulrich Thienel

Chief Development & Medical Officer, RRD International